Monograph Title | Section Sort descending | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
RANITIDINE TABLETS | USP Reference standards <11> | USP39–NF34 | 5672 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Line 2 of USP Ranitidine Related Compound C RS: Change N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine. to: N-{2-[({5-[(Dimethylamino)methyl]-2-furanyl}methyl)sulfinyl]ethyl}-N′-methyl-2-nitro-1,1-… Read More |
FOSPHENYTOIN SODIUM INJECTION | USP Reference standards <11> | USP36–NF31 | 3680 | 31-May-2013 | 1-Jun-2013 | USP37–NF32 | USP37–NF32 | Line 6: Change C14H15NO2 to: C14H13NO2 |
GRANISETRON HYDROCHLORIDE INJECTION | USP Reference standards <11> | USP39–NF34 | 4153 | 29-Jul-2016 | 1-Aug-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 2 of USP Granisetron Related Compound B RS: Change (N-[(1R,3r,5)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide). to: N-[(1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide. |
GRANISETRON HYDROCHLORIDE TABLETS | USP Reference standards <11> | First Supplement to USP40–NF35 | Online | 31-Mar-2017 | 1-Apr-2017 | USP41–NF36 | USP41–NF36 | Line 3 of USP Granisetron Related Compound C RS: Change carboxamide. to: carboxamide hydrochloride. |
RANITIDINE IN SODIUM CHLORIDE INJECTION | USP Reference standards <11> | USP39–NF34 | 5673 | 27-May-2016 | 1-Jun-2016 | USP40–NF35 | USP40–NF35 | Line 2 of USP Ranitidine Related Compound C RS: Change N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine. to: N-{2-[({5-[(Dimethylamino)methyl]-2-furanyl}methyl)sulfinyl]ethyl}-N′-methyl-2-nitro-1,1-… Read More |
RISPERIDONE | USP Reference standards <11> | USP36–NF31 | 5063 | 22-Nov-2013 | 1-Dec-2013 | USP38–NF33 | Second Supplement to USP37–NF32 | Line 7 of USP Risperidone System Suitability Mixture RS: Change 9-Hydroxyrisperidone-(6RS)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2,6-dimethyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one. to: 9-Hydroxyrisperidone: (9RS)-3-{2-[4-(6… Read More |
FENOLDOPAM MESYLATE | USP Reference standards <11> | USP40–NF35 | 4159 | 29-Sep-2017 | 1-Oct-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Line 2 of USP Fenoldopam Related Compound A RS: Change 1-Methyl-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate (salt). C17H18ClNO3 · CH4SO3 415.89 to: 6-Chloro-1-(4-hydroxyphenyl)-3-… Read More |
CARISOPRODOL, ASPIRIN, AND CODEINE PHOSPHATE TABLETS | USP Reference standards <11> | USP36–NF31 | 2813 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 2 of USP Codeine N-Oxide RS: Change C18H21O4 to: C18H21NO4 |
GRANISETRON HYDROCHLORIDE TABLETS | USP Reference standards <11> | USP39–NF34 | 4155 | 29-Jul-2016 | 1-Aug-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 2 of USP Granisetron Related Compound B RS: Change (N-[(1R,3r,5)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide). to: N-[(1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide. |
CILOSTAZOL | USP Reference standards <11> | USP40–NF35 | 3418 | 17-Nov-2017 | 1-Dec-2017 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Cilostazol Related Compound C RS: Change 1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one. C31H43N9O3 589.73 to: 1-(4-(1-Cyclohexyl-1… Read More |
ZILEUTON | USP Reference standards <11> | USP43–NF38 | 4679 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Zileuton Related Compound A RS: Change N-(1-Benzo-[b]thien-2-ylethyl)urea. C11H12N2OS 220.30 to: N-(1-Benzo-[b]thien-2-ylethyl)urea; Also known as 1-[1-(Benzo… Read More |
FOLIC ACID INJECTION | USP Reference standards <11> | USP41–NF36 | 1866 | 27-Jul-2018 | 1-Aug-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete USP Endotoxin RS |
ONDANSETRON HYDROCHLORIDE | USP Reference standards <11> | USP40–NF35 | 5441 | 28-Jul-2017 | 1-Aug-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Line 2 of USP Ondansetron Related Compound A RS: Change 3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one. to: 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. |
MELENGESTROL ACETATE | USP Reference standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Melengestrol Acetate Related Compound A RS: Change 16-Methylene-17α-hydroxy-4-pregnene-3,20-dione 17-acetate. to: 16-Methylene-3,20-dioxopregn-4-en-17-yl acetate. AND In USP Melengestrol Acetate Related Compound B RS: Change 17α-… Read More |
ONDANSETRON INJECTION | USP Reference Standards | USP35–NF30 | 4120 | 31-Jan-2013 | 1-Feb-2013 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 7: Delete USP Ondansetron Related Compound B RS 6,6´-Methylene bis-[(1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)-methyl]-4H-carbazol-4-one. |
ONDANSETRON HYDROCHLORIDE | USP Reference standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride. AND… Read More |
ONDANSETRON INJECTION | USP Reference standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride. AND… Read More |
MECAMYLAMINE HYDROCHLORIDE | USP Reference standards <11> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In USP Mecamylamine Related Compound A RS: Change N,1,7,7-Tetramethyl bicyclo [2.2.1]heptan-2-amine. C11H21N 167.29 to: N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride. C11… Read More |
<1050> VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS DERIVED FROM CELL LINES OF HUMAN OR ANIMAL ORIGIN | VI. Evaluation and Characterization of Viral Clearance Procedures | USP35–NF30 | 553 | 31-Jan-2013 | 1-Feb-2013 | USP37–NF32 | Second Supplement to USP36–NF31 | Row 10 (Reovirus 3) of Column 5 (Genome) of Table A-1: Change DNA to: RNA |
RIMEXOLONE OPHTHALMIC SUSPENSION | Viscosity—Capillary Viscometer Methods <911> and Rotational Rheometer Methods <912> | USP36–NF31 | 5053 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 1: Change and to: or |
ETHIODIZED OIL INJECTION | Viscosity—Capillary Viscometer Methods <911> and Rotational Rheometer Methods <912> | USP36–NF31 | 3505 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 1: Change and to: or |
FERUMOXSIL ORAL SUSPENSION | Viscosity—Capillary Viscometer Methods <911> and Rotational Rheometer Methods <912> | USP36–NF31 | 3572 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 1: Change and to: or |
<698> DELIVERABLE VOLUME | ACCEPTANCE CRITERIA/For Multiple-Unit Containers | First Supplement to USP35–NF30 | 5154 | 28-Sep-2012 | 1-Oct-2012 | USP37–NF32 | First Supplement to USP36–NF31 | Figure 1, right branch, left box: Change
Volume of 1 more containers is less than 95% LV to: Volume of 1 or more containers is less than 95% LV |
STERILE PURIFIED WATER | ADDITIONAL REQUIREMENTS | USP37–NF32 | 5176 | 26-Sep-2014 | 1-Oct-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Add a section: USP Reference Standards <11> USP 1,4-Benzoquinone RS USP Sucrose RS |
ANTITHROMBIN III HUMAN | ADDITIONAL REQUIREMENTS | USP42–NF37 | 350 | 27-Mar-2020 | 1-Apr-2020 | NA | NA | In Labeling: Change USP Antithrombin III Units. to: Antithrombin III IU. |
DILUTED ALCOHOL | ADDITIONAL REQUIREMENTS | USP36–NF31 | 1874 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Delete USP Reference Standards <11> section |
AZITHROMYCIN | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Azaerythromycin A RS: Change 734.96 to: 734.97 AND In USP Azithromycin Related Compound F RS: Change 762.97 to: 762.98 AND In USP Desosaminylazithromycin RS: Change 590.79 to: 590.80 |
STERILE WATER FOR IRRIGATION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4347 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
AZITHROMYCIN FOR INJECTION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | USPNF 2024 Issue 2 | In USP Reference Standards 〈11〉/USP Azaerythromycin A RS: Change 734.96 to: 734.97 AND In USP Azithromycin N-oxide RS: Change 764.98 to: 765.00 AND In USP N-Demethylazithromycin RS: Change 734.96 to: 734.97… Read More |
METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS | USP43–NF38 | 2918 | 31-Jul-2020 | 1-Aug-2020 | NA | NA | In Labeling: Change as metoprolol succinate [(C15H25NO3)2 · C4H6O6]. to: as metoprolol tartrate [(C15H25NO3)2 · C4… Read More |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Dihydrodutasteride RS: Change N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide. to: N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androstane-17β-carboxamide. |
ROPIVACAINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS | USP43–NF38 | 3943 | 29-May-2020 | 1-Jun-2020 | NA | NA | In USP Reference Standards <11>/USP Ropivacaine Related Compound A RS: Change 2,6-Dimethylaniline hydrochloride. C8H12ClN 157.64 [CAS-21436-98-6]. to: 2,6-Dimethylaniline hydrochloride. C8H11… Read More |
PURIFIED WATER | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4347 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
RACEPINEPHRINE INHALATION SOLUTION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 3564 | 27-Jul-2018 | 1-Aug-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Add USP Reference Standards <11> USP Epinephrine Bitartrate RS |
PRAVASTATIN SODIUM | ADDITIONAL REQUIREMENTS | USP43–NF38 | 3645 | 29-May-2020 | 1-Jun-2020 | NA | NA | In USP Reference Standards <11>/USP Pravastatin Related Compound A RS: Change 446.51 to: 446.52 |
REPOSITORY CORTICOTROPIN INJECTION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 1097 | 27-Apr-2018 | 1-May-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | In USP Reference Standards <11>: Add USP Ascorbic Acid RS |
IODIXANOL INJECTION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In USP Reference Standards 〈11〉/USP Iodixanol Related Compound E RS: Change 5-[[3-[[3-[[(2,3-Dihydroxypropyl)amino]carbonyl]-5- [[amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-… Read More |
SALIX SPECIES BARK POWDER | ADDITIONAL REQUIREMENTS | USP42–NF37 | 5189 | 25-Jan-2019 | 1-Feb-2019 | NA | NA | In Labeling: Change The label states the Latin binomial(s) of one or several Salix species included in the article. to: The label states the Latin binomial(s) of one or several Salix species included in the article. Dosage forms… Read More |
CRANBERRY FRUIT DRY JUICE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS |
VITAMIN A | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4327 | 28-Dec-2018 | 1-Jan-2019 | NA | NA | Change Delete the following ▲•USP Reference Standards <11> USP Retinyl Acetate RS USP Retinyl Palmitate RS ▲(CN 1-May-2018) to: •USP Reference Standards <11> USP Retinyl Acetate RS … Read More |
EPINEPHRINE | ADDITIONAL REQUIREMENTS | USP43–NF38 | Online | 24-Apr-2020 | 1-May-2020 | NA | NA | This erratum applies to the USP-NF ONLINE platform only. In USP Reference Standards <11>: Add USP Racepinephrine Hydrochloride RS |
STERILE PURIFIED WATER | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4348 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
PURE STEAM | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4348 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
MIRTAZAPINE TABLETS | ADDITIONAL REQUIREMENTS | USP43–NF38 | 2978 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Reference Standards <11>/USP Mirtazapine Resolution Mixture RS: Change This resolution mixture contains approximately 0.1% w/w each of the following: Impurity A: 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c… Read More |
RIVASTIGMINE TARTRATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In USP Reference Standards 〈11〉: Change USP Rivastigmine Tartrate R-Isomer RS to: USP Rivastigmine Tartrate R-Isomer RS (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate. C14H22N2… Read More |
MIRTAZAPINE | ADDITIONAL REQUIREMENTS | USP43–NF38 | 2976 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Reference Standards <11>/USP Mirtazapine Resolution Mixture RS: Change This resolution mixture contains approximately 0.1% w/w each of the following: Impurity A: 1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c… Read More |
TRIAMTERENE | ADDITIONAL REQUIREMENTS | First Supplement to USP41–NF36 | Online | 28-Sep-2018 | 1-Oct-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | This erratum applies to the new USP-NF ONLINE platform only. Line 4 of USP Reference Standards <11>: Change USP Doxazosin Related Compound A RS to: USP Triamterene Related Compound A RS |
SODIUM SALICYLATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉: Add USP Phenol RS |
LEVETIRACETAM | ADDITIONAL REQUIREMENTS | USP35–NF30 | 3659 | 29-Mar-2013 | 1-Apr-2013 | USP37–NF32 | USP37–NF32 | Line 9 of USP Reference Standards <11>: Change
C8H14ClNO3 207.65 to: C8H15ClN2O2 206.67 |
REPOSITORY CORTICOTROPIN INJECTION | ADDITIONAL REQUIREMENTS | USP43–NF38 | 1174 | 24-Apr-2020 | 1-May-2020 | NA | NA | In USP Reference Standards <11>: Add USP Ascorbic Acid RS |